Together with our partners, we make the GARD® assay available to the market on both a local, regional and global level.

SenzaGen will set up the GARD® assay in several CRO globally and we are always looking for new partners. The validation and ring trial of the GARD® assay for OECD/ECVAM approval has proven the assay to be easy to set up, easy to perform and extremely robust.

If you are interested in becoming partner to SenzaGen please meet us at one of the meetings we attend, contact our Chief Commercial Officer, Anna Chérouvrier Hansson or reach out to your preferred point of contact within the company.

Most welcome!